539.75
-7.72
(-1.41%)
At close: January 13 at 4:00:01 PM EST
540.67
+0.92
+(0.17%)
Pre-Market: 6:20:36 AM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
1,820,700.00
1,813,800.00
1,490,800.00
2,089,400.00
1,484,800.00
Investing Cash Flow
-3,052,800.00
-360,100.00
1,370,800.00
-2,461,500.00
-940,600.00
Financing Cash Flow
70,000.00
-287,600.00
-2,572,300.00
43,000.00
-85,700.00
End Cash Position
2,460,800.00
2,770,100.00
1,600,700.00
1,306,000.00
1,638,500.00
Capital Expenditure
-1,234,700.00
-1,064,200.00
-532,400.00
-339,500.00
-341,500.00
Repurchase of Capital Stock
-66,300.00
-416,300.00
-2,607,400.00
--
-134,300.00
Free Cash Flow
586,000.00
749,600.00
958,400.00
1,749,900.00
1,143,300.00
12/31/2020 - 6/16/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALGN Align Technology, Inc.
213.68
+0.74%
MBOT Microbot Medical Inc.
1.7800
-7.77%
BDX Becton, Dickinson and Company
236.19
+1.08%
RMD ResMed Inc.
230.26
-1.52%
GCTK GlucoTrack, Inc.
0.1497
+27.95%
BNGO Bionano Genomics, Inc.
0.2229
-1.63%
BAX Baxter International Inc.
30.50
+3.67%
ANGO AngioDynamics, Inc.
12.46
+1.30%
HOLX Hologic, Inc.
70.29
-1.97%
POAI Predictive Oncology Inc.
1.2800
-5.88%